Diagnosis and treatment of hemodynamic disorders and especially hypertension in obese patients is a medico-social problem. Dynamic monitoring and control of the treatment with a non-invasive method of examination is required for these patients with labile psycho-emotional status. Dynamics control is necessary during a certain period of time and with a computer program evaluating the obtained results. The authors examined the patients with obesity on the complex Simon III, allowing to carrying out a comprehensive survey of non-invasive dynamic within a few minutes of observation with the software of the survey process. From a study of the literature suggests that overweight reduces contractility and diastolic function. The examination of 14 men (who do not have acute and chronic diseases, without bad habits, aged (29-52 years) revealed an inverse relationship between increasing body mass index and the index of myocardial contractility (r = -0.62, p <98 %) and the feedback correlation inotropy condition index (r = - 0,75, p <99%)., stroke index and left ventricular work fell well within the normal range of values. Such a detailed interpretation of hemodynamics makes it possible to more reasonable therapy of hypertension and prediction of outcomes in patients with obesity.
obesity, hemodynamics, evaluation
1. Antonov A.A. Gemodinamika dlya klinitsista (fiziologicheskie aspekty). Arkomis-ProfiTT, 2004. 99 s.
2. Antonov A.A., Burov N.E. Sistemnyy apparatnyy monitoring. Vestnik intensivnoy terapii. 2010. №3. S. 8-12.
3. Antonov A.A. Beznagruzochnaya otsenka funktsional´nogo sostoyaniya sportsmenov. Poliklinika 2013. №1. S. 37-41.
4. Astashkin E.I., Glezer M.G.. Ozhirenie i arterial´naya gipertoniya. Problemy zhenskogo zdo-rov´ya. 2008. T. 3, № 4. S. 23-33.
5. Kireev S.S., Tokarev A.R., MalychenkoT.V. Genderno-klimaticheskie osobennosti obrashchaemo-sti naseleniya za meditsinskoy pomoshch´yu po povodu arterial´noy gipertenzii. Vestnik novykh medi-tsinskikh tekhnologiy. Elektronnoe izdanie. 2014. №1. Publikatsiya 7-11. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2014-1/4843.pdf (Data publikatsii: 19.09.2014). DOI:https://doi.org/10.12737/5762.
6. Lopatkina L.V. Vliyanie kompleksnoy reabilitatsii s vklyucheniem innovatsionnykh tekhnolo-giy na sostoyanie gemodinamiki u patsientov s metabolicheskim sindromom. Vestnik novykh meditsin-skikh tekhnologiy. Elektronnoe izdanie. 2013. №1. Publikatsiya 2-168. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2013-1/4635.pdf (Data publikatsii: 25.11.2013).
7. Lushnov M.S., Kidalov V.N., Khadartsev A.A., Es´kov V.M. Vliyanie ritmov geokosmosa na funk-tsional´noe sostoyanie organizma i sistemu krovi: Monografiya / Pod red. A.A. Khadartseva. Sankt-Peterburg - Tula: OOO RIF «INFRA», 2007. 188 c.
8. Klinicheskie rekomendatsii [Rekomendatsii po vedeniyu bol´nykh s metabolicheskim sindro-mom] / Chazov E.I. [i dr.]. Rossiyskoe meditsinskoe obshchestvo po arterial´noy gipertonii, 2013. S. 43.
9. Aneja A., El-Atat F., McFarlane S.I., Sowers J.R. Hypertension and obesity. Recent ProgrHorm Res 2004. V. 59. P. 169-205.
10. Plasma insulin, leptin, and soluble TNF receptoirs levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men / Chu N.F., Spiegelman D., Hotamisligil G.S., [et al.]. Atheroslerosis. 2001. V. 157. P. 495-503.
11. Davidson R.C, Ahmad S. Hemodynamic profiles in essential and secondary hypertension. In: Izzo J.L, Black H.R. editor. Hypertension Primer (The Essentials of High Blood Pressure). Dallas: Council on High Blood Pressure Research (American Heart Association); 2003;Third Edition.R.343
12. Engeli S., Sharma A.M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med. 2001. V. 79. P. 21-29.
13. Hajer G.R., van Haeften T.W., Visseren F.L.J. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008. V. 29. P. 2959-2971.
14. Hall J.E. The kidney, hypertension and obesity. Hypertension. 2003. V. 41(3). P. 625-633.
15. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobiliza-tion, and systemic nonesterified fatty acids levels in humans / Lafontan M., Moro C., Sengenes C., [et al.]. Ar-terioscler Thromb Vasc Biol. 2005. V. 25. P. 2032-2042.
16. Obesity, blood pressure, and the sympathetic nervous system / Landsberg L., Troisi R., Parker D., [et al.]. Ann Epidemiol. 1991. V. 1. P. 295-303.
17. Milnor W.R. Hemodynamics. Williams & Wilkins, 1982. P. 136, 155.
18. Shi J.R. Cardiac structure and function in young athletes. Diss. Master of Science. Victoria University of Technology, USA, 2002. R.341
19. Sramek B.B. Hemodynamics and its role in oxygen transport. Biomechanics of the Cardiovascular System. CzechTechnicalUniversityPress, 1995. P. 209-231.
20. INTERSALT study findings. Public health and medical care implications / Stamler J., Rose G., Stam-ler R. [et al.] . Hypertension. 1989. V. 14(5). P. 570-577.
21. Tentolouris N., Liatis S., Katsilambros N. Sympathetic system activity in obesity and metabolic syn-drome. Ann N Y AcadSci. 2006. V. 1083. P. 129-152.
22. Vanfraechem J.H.P. Stroke volume and systolic time interval adjustments during bicycle ergometer. J. Appl. Physiol. 1979. V. 46. P. 588-592.
23. Adipokines and risk of type 2 diabetes in older men / Wannamethee S.G., Lowe G.D., Rumley A. [et al.]. Diabetes Core. 2007. V. 30. P. 1200-1205.
24. Wilmore J.H., Costill D.L. Physiology of Sport and Exercise: 3rd Edition. Champaign, IL: Human Kinetics, 2005.
